615 related articles for article (PubMed ID: 19204302)
1. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.
Blake GJ; Otvos JD; Rifai N; Ridker PM
Circulation; 2002 Oct; 106(15):1930-7. PubMed ID: 12370215
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
[TBL] [Abstract][Full Text] [Related]
7. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
[TBL] [Abstract][Full Text] [Related]
8. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank.
Jin D; Trichia E; Islam N; Bešević J; Lewington S; Lacey B
J Am Heart Assoc; 2023 Oct; 12(20):e029552. PubMed ID: 37815053
[TBL] [Abstract][Full Text] [Related]
12. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker.
Berends AMA; Buitenwerf E; Gruppen EG; Sluiter WJ; Bakker SJL; Connelly MA; Kerstens MN; Dullaart RPF
Clin Endocrinol (Oxf); 2019 Jan; 90(1):79-87. PubMed ID: 30372543
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort.
Parikh NI; Gerschenson M; Bennett K; Gangcuangco LM; Lopez MS; Mehta NN; Playford MP; Nakamoto BK; Seto TB; Chow DC; Shikuma CM
Atherosclerosis; 2015 Mar; 239(1):50-4. PubMed ID: 25574857
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
15. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
[TBL] [Abstract][Full Text] [Related]
16. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical association of lipoprotein measures with incident atrial fibrillation.
Mora S; Akinkuolie AO; Sandhu RK; Conen D; Albert CM
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):612-9. PubMed ID: 24860180
[TBL] [Abstract][Full Text] [Related]
18. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
Ridker PM; Rifai N; Cook NR; Bradwin G; Buring JE
JAMA; 2005 Jul; 294(3):326-33. PubMed ID: 16030277
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein cholesterol versus particle number in middle school children.
Mietus-Snyder M; Drews KL; Otvos JD; Willi SM; Foster GD; Jago R; Buse JB;
J Pediatr; 2013 Aug; 163(2):355-62. PubMed ID: 23415622
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
